(Q44963191)

7 December 2017

title

Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice (English)

1 reference

7 December 2017

1 reference

7

1 reference

7 December 2017

6

Bettina Heid

1 reference

7 December 2017

Naveen Surendran

1

1 reference

7 December 2017

Nammalwar Sriranganathan

2

1 reference

7 December 2017

Heather Lawler

3

1 reference

7 December 2017

Stephen M Boyle

4

1 reference

7 December 2017

Elizabeth M Hiltbold

5

1 reference

7 December 2017

Sharon G Witonsky

8

1 reference

7 December 2017

language of work or name

English

0 references

publication date

20 February 2011

1 reference

7 December 2017

1 reference

7 December 2017

volume

29

1 reference

7 December 2017

issue

15

1 reference

7 December 2017

page(s)

2749-2755

1 reference

Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Brucella as a biological weapon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

An aerosolized Brucella spp. challenge model for laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Biological properties of RB51; a stable rough strain of Brucella abortus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Mucosal vaccines: the promise and the challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Smooth Brucella strains invade and replicate in human lung epithelial cells without inducing cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.090

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.01.090

1 reference

7 December 2017

1 reference